Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Prattes, J; Hoenigl, M; Krause, R; Buzina, W; Valentin, T; Reischies, F; Koidl, C; Zollner-Schwetz, I.
Invasive aspergillosis in patients with underlying liver cirrhosis: a prospective cohort study.
Med Mycol. 2017; 55(8):803-812 Doi: 10.1093/mmy/myx011 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG


Führende Autor*innen der Med Uni Graz
Prattes Jürgen
Co-Autor*innen der Med Uni Graz
Buzina Walter
Hönigl Martin
Koidl Christoph
Krause Robert
Reischies-Meikl Frederike Marie Josefine
Valentin Thomas
Zollner-Schwetz Ines

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

The aim of this study was to determine the prevalence of invasive aspergillosis (IA) in patients with liver cirrhosis and the performance of serum galactomannan (GM) screening. Patients with decompensated liver cirrhosis and patients with compensated liver cirrhosis presenting with fever and/or respiratory symptoms were prospectively enrolled. All patients were screened by serum GM twice weekly irrespective of clinical signs and symptoms. Positive serum GM triggered work-up consisting of chest computed tomography and in case of pathological findings bronchoscopy. 150 patients were included in the study. Two (1.3%) had probable, one (0.7%) had possible, and 147 (98%) had no evidence of IA. Both patients with probable IA had compensated liver cirrhosis. Sensitivity for serum GM screening for probable versus no IA was 0.5 (95% CI, 0.09-0.91), specificity 0.97 (95% CI: 0.92-0.99), negative predictive value 0.99 (95% CI, 0.96-0.99) and positive predictive value (PPV) 0.17 (95% CI, 0.01-0.64). PPV was 0.5 (95% CI, 0.03-0.98) in patients with clinical suspicion of IA. In conclusion, prevalence of IA in patients with liver cirrhosis seems to be low. Targeted GM testing in case of clinical suspicion of IA may be associated with markedly higher PPVs when compared to universal GM screening in patients with liver cirrhosis. © The Author 2017. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology. All rights reserved. For permissions, please e-mail:
Find related publications in this database (using NLM MeSH Indexing)
Aged -
Aspergillosis - blood
Aspergillosis - complications
Aspergillosis - diagnosis
Aspergillosis - mortality
Cohort Studies -
Female -
Humans -
Kaplan-Meier Estimate -
Liver Cirrhosis - blood
Liver Cirrhosis - complications
Male -
Mannans - blood
Middle Aged -
Prevalence -
Prospective Studies -
Sensitivity and Specificity -

Find related publications in this database (Keywords)
liver cirrhosis
© Med Uni Graz Impressum